Department of Cardiology, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, China.
Psychopharmacology (Berl). 2024 Apr;241(4):637-651. doi: 10.1007/s00213-024-06552-6. Epub 2024 Feb 26.
Nowadays, high morbidity and mortality of cardiovascular diseases (CVDs) and high comorbidity rate of neuropsychiatric disorders contribute to global burden of health and economics. Consequently, a discipline concerning abnormal connections between the brain and the heart and the resulting disease states, known as psychocardiology, has garnered interest among researchers. However, identifying a common pathway that physicians can modulate remains a challenge. Gut microbiota, a constituent part of the human intestinal ecosystem, is likely involved in mutual mechanism CVDs and neuropsychiatric disorder share, which could be a potential target of interventions in psychocardiology. This review aimed to discuss complex interactions from the perspectives of microbial and intestinal dysfunction, behavioral factors, and pathophysiological changes and to present possible approaches to regulating gut microbiota, both of which are future directions in psychocardiology.
如今,心血管疾病(CVDs)的高发病率和高死亡率以及神经精神疾病的高合并率导致了全球健康和经济负担。因此,一门关注大脑和心脏之间异常联系及其导致的疾病状态的学科,即心理心脏病学,引起了研究人员的兴趣。然而,确定医生可以调节的共同途径仍然是一个挑战。肠道微生物群是人类肠道生态系统的组成部分,可能参与了 CVDs 和神经精神疾病共有的相互作用机制,这可能是心理心脏病学干预的一个潜在靶点。本综述旨在从微生物和肠道功能障碍、行为因素以及病理生理变化的角度讨论复杂的相互作用,并提出调节肠道微生物群的可能方法,这两者都是心理心脏病学的未来方向。